These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
208 results:

  • 1. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
    Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
    [No Abstract]    [Full Text] [Related]  

  • 2. LINC00662 Promotes Aggressive Traits by Modulating oct4 Expression through miR-335-5p in Gallbladder cancer Cells.
    Pérez-Moreno P; Riquelme I; Bizama C; Vergara-Gómez L; Tapia JC; Brebi P; García P; Roa JC
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928444
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High-tailored Anal Canal Radiotherapy (HIT-ART): Outcomes of a 10-Year Single Center Clinical Experience.
    Manfrida S; Fionda B; Mariani S; Luca V; Bertolini R; Barbaro B; Chiloiro G; Frascino V; Tagliaferri L; Gambacorta MA
    In Vivo; 2024; 38(3):1306-1315. PubMed ID: 38688632
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
    Levy A; Morel D; Texier M; Sun R; Durand-Labrunie J; Rodriguez-Ruiz ME; Racadot S; Supiot S; Magné N; Cyrille S; Louvel G; Massard C; Verlingue L; Bouquet F; Bustillos A; Bouarroudj L; Quevrin C; Clémenson C; Mondini M; Meziani L; Tselikas L; Bahleda R; Hollebecque A; Deutsch E
    Mol Cancer; 2024 Mar; 23(1):61. PubMed ID: 38519913
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Metastases and treatment-resistant lineages in patient-derived cancer cells of colorectal cancer.
    Fujino S; Miyoshi N; Ito A; Hayashi R; Yasui M; Matsuda C; Ohue M; Horie M; Yachida S; Koseki J; Shimamura T; Hata T; Ogino T; Takahashi H; Uemura M; Mizushima T; Doki Y; Eguchi H
    Commun Biol; 2023 Nov; 6(1):1191. PubMed ID: 37996567
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. cancer Stem Cells Persist Despite Cellular Damage, Emergence of the Refractory Cell Population.
    Nagae A; Miyoshi N; Fujino S; Horie M; Yachida S; Sasaki M; Sekido Y; Hata T; Hamabe A; Ogino T; Takahashi H; Uemura M; Yamamoto H; Doki Y; Eguchi H
    Ann Surg Oncol; 2023 Oct; 30(11):6913-6924. PubMed ID: 37523119
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Isoliensinine augments the therapeutic potential of paclitaxel in multidrug-resistant colon cancer stem cells and induced mitochondria-mediated cell death.
    Manogaran P; Anandan A; Vijaya Padma V
    J Biochem Mol Toxicol; 2023 Aug; 37(8):e23395. PubMed ID: 37424111
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
    Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gradient-based Volumetric PET Parameters on Immediate Pre-ablation FDG-PET Predict Local Tumor Progression in Patients with colorectal Liver Metastasis Treated by Microwave Ablation.
    Zirakchian Zadeh M; Yeh R; Kirov AS; Kunin HS; Gönen M; Sotirchos VS; Soares KS; Sofocleous CT
    Cardiovasc Intervent Radiol; 2023 Jul; 46(7):911-920. PubMed ID: 37268735
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization.
    Feng WQ; Zhang YC; Gao H; Li WC; Miao YM; Xu ZF; Xu ZQ; Zhao JK; Zheng MH; Zong YP; Lu AG
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203394
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ALDH2 promotes cancer stemness and metastasis in colorectal cancer through activating β-catenin signaling.
    Wei PL; Prince GMSH; Batzorig U; Huang CY; Chang YJ
    J Cell Biochem; 2023 Jun; 124(6):907-920. PubMed ID: 37183314
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Stemness targeting of colorectal cell lines mediated by BAMLET and 5-Flourouracil.
    Babazadeh M; Zamani M; Mehrbod P; Mokarram P
    Biochem Biophys Res Commun; 2023 Jul; 664():136-141. PubMed ID: 37167706
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. FAK downregulation suppresses stem-like properties and migration of human colorectal cancer cells.
    Xu C; Zhang W; Liu C
    PLoS One; 2023; 18(4):e0284871. PubMed ID: 37083591
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Association of NRF2 with HIF-2α-induced cancer stem cell phenotypes in chronic hypoxic condition.
    Hallis SP; Kim SK; Lee JH; Kwak MK
    Redox Biol; 2023 Apr; 60():102632. PubMed ID: 36791645
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Modulation of rectal cancer stemness, patient outcome and therapy response by adipokines.
    Marques V; Ourô S; Afonso MB; Rodrigues CMP
    J Physiol Biochem; 2023 May; 79(2):261-272. PubMed ID: 36495464
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Abberant Immunohistochemical Expression of oct3/4 and EMT Related Markers, Vimentin and E-cadherin, is Correlated with Adverse Histopathological Features in colorectal Adenocarcinoma.
    Busuioc C; Birla RD; Ultimescu F; Duţulescu S; Panaitescu E; Berindan-Neagoe I
    Chirurgia (Bucur); 2022 Oct; 117(5):544-555. PubMed ID: 36318684
    [No Abstract]    [Full Text] [Related]  

  • 17. oct4 promoted proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in colon cancer cells by activating the SCF/c-Kit signaling pathway.
    Bu X; Liu Y; Wang L; Yan Z; Xin G; Su W
    Cell Cycle; 2023 Feb; 22(3):291-302. PubMed ID: 36258646
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer.
    Chen J; Wu Z; Zhang X; Liu Z; Wang Y; Shan F; Wang Y; Xia S; Zhang Y; Sun Y; Ji J; Li Z
    Int J Colorectal Dis; 2022 Nov; 37(11):2321-2333. PubMed ID: 36243807
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FK866 inhibits colorectal cancer metastasis by reducing NAD
    Xie H; Lei Y; Mao Y; Lan J; Yang J; Quan H; Zhang T
    Genes Genomics; 2022 Dec; 44(12):1531-1541. PubMed ID: 36214983
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Circ_0001535 Facilitates Tumor Malignant Progression by miR-485-5p/LASP1 Axis in colorectal cancer.
    Bai L; Gao Z; Jiang A; Ren S; Wang B
    Balkan Med J; 2022 Nov; 39(6):411-421. PubMed ID: 36172827
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.